Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(4):308-313
This paper provides a review of the largest studies (over the period of 2017 to 2022) on the use of fecal microbiota transplantation (FMT) for the treatment of patients with recurrent *Clostridioides difficile*associated diarrhea (CDAD), including …